Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma

When to perform hepatic resection for intermediate-stage hepatocellular carcinoma

(2015) Alessandro Cucchetti et al.   HEPATOLOGY

Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma

(2015) Jing-Houng Wang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group

(2014) Simona Leoni et al.   DIGESTIVE AND LIVER DISEASE

Improving survival of cirrhosis patients with hepatocellular carcinoma through application of standard of care

(2014) Edoardo G. Giannini et al.   HEPATOLOGY

Prognosis of untreated hepatocellular carcinoma

(2014) Edoardo G. Giannini et al.   HEPATOLOGY

Prognosis of patients with intermediate-stage hepatocellular carcinomas based on the Child-Pugh score: subclassifying the intermediate stage (Barcelona Clinic Liver Cancer stage B)

(2014) Koichiro Yamakado et al.   JAPANESE JOURNAL OF RADIOLOGY

Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

(2014) Annagiulia Gramenzi et al.   LIVER INTERNATIONAL

Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients

(2014) Arndt Weinmann et al.   LIVER INTERNATIONAL

Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study

(2013) Cristina Ripoll et al.   HEPATOLOGY

Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer stage B subclassification by survival analysis

(2013) Yeonjung Ha et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

109 CLINICAL VALIDATION OF A SUB-STAGING PROPOSAL OF PATIENTS WITH INTERMEDIATE HCC (BCLC-B)

(2013) F. Piscaglia et al.   JOURNAL OF HEPATOLOGY

Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it?

(2013) Edoardo G Giannini   WORLD JOURNAL OF GASTROENTEROLOGY

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

(2012) Jordi Bruix et al.   JOURNAL OF HEPATOLOGY

1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY

(2012) J.M. Llovet et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Underutilization of therapy for hepatocellular carcinoma in the medicare population

(2010) Shimul A. Shah et al.   CANCER

The intermediate hepatocellular carcinoma stage: Should treatment be expanded?

(2010) Fabio Piscaglia et al.   DIGESTIVE AND LIVER DISEASE

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States

(2010) Jessica A. Davila et al.   HEPATOLOGY

Prognostication of the outcome of hepatocellular carcinoma: How to rely on science instead of on the art of Nostradamus

(2009) Franco Trevisani et al.   DIGESTIVE AND LIVER DISEASE

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

(2008) Vincenzo Mazzaferro et al.   LANCET ONCOLOGY